Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Plos One|November 22, 2007
SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPDLukasz P Gondek, Andrew J Dunbar, Hadrian Szpurka, et al.
Blood|October 24, 2007
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AMLLukasz P Gondek, Ramon Tiu, Christine L O'Keefe, et al.
British Journal of Haematology|May 24, 2021
Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromesTheodoros Karantanos, Lukasz P Gondek, Ravi Varadhan, et al.
Blood|April 15, 2006
Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndromeMarcin W Wlodarski, Lukasz P Gondek, Zachary P Nearman, et al.
Blood|October 4, 2008
Aberrant DNA methylation is a dominant mechanism in MDS progression to AMLYing Jiang, Andrew Dunbar, Lukasz P Gondek, et al.
Cancer Research|March 16, 2026
DNA Methylation Stochasticity is Linked to Transcriptional Variability and Convergent Epigenetic Disruption Across Genetic Subtypes of Acute Myeloid LeukemiaEleanor Hilgart, Weiqiang Zhou, Eduardo Martinez-Montes, et al.
Nature Communications|February 18, 2026
Mitochondrial heteroplasmy is a risk factor for the development of chronic lymphocytic leukemiaSergiu Pasca, Yun Soo Hong, Wen Shi, et al.
Haematologica|October 16, 2025
Lenalidomide-associated reversible TP53-mutated clonal hematopoiesis in plasma cell neoplasmsChristian B Gocke, Mareike Peters, Christopher D Gocke, et al.
Experimental Hematology|October 9, 2007
Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromesLukasz P Gondek, Abdo S Haddad, Christine L O'Keefe, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamideNiveditha Ravindra, Laura W Dillon, Gege Gui, et al.
Pageof 7